Clinical effects of metoprolol in obstructive hypertrophic cardiomyopathy (TEMPO). A randomized, double-blinded, placebo-controlled crossover trial

Back

ESC Premium Access

Clinical effects of metoprolol in obstructive hypertrophic cardiomyopathy (TEMPO). A randomized, double-blinded, placebo-controlled crossover trial

Session: Myocardial and pericardial disease e-posters

Topic: Hypertrophic Cardiomyopathy

Speaker: Mrs A. Dybro (Aarhus, DK)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Mrs Anne Dybro

Aarhus University Hospital, Aarhus (Denmark)

0 follower

93 more presentations in this session

Combination of arrhythmogenic right ventricular dysplasia with left ventricular non-compaction as a special form of cardiomyopathy: clinic, diagnostics, genetic, natural course

Speaker: Professor O. Blagova (Moscow, RU)

Access

Abstract

Slides

Efficacy and safety of alcohol septal ablation in adolescents and young adults with symptomatic hypertrophic obstructive cardiomyopathy

Speaker: Doctor D. Lawin (Bielefeld, DE)

Access

Abstract

Slides

Cardiac rupture - the most serious complication of takotsubo syndrome

Speaker: Doctor M. Zalewska-Adamiec (Bialystok, PL)

Access

Abstract

Slides

Noncompact myocardium with dilated phenotype: differences in comparison with other forms of dilated cardiomyopathy..

Speaker: Professor O. Blagova (Moscow, RU)

Access

Abstract

Slides

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA in patients with hypertrophic cardiomyopathy

Speaker: Doctor A. Trongtorsak (Evanston, US)

Access

Abstract

Slides

Access the full session

Myocardial and pericardial disease e-posters

Speakers: Mrs A. Dybro, Professor O. Blagova, Doctor D. Lawin, Doctor M. Zalewska-Adamiec, Professor O. Blagova...

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources